The Isoray Cesium-131 Implant Devices combined with MRI Markers will be used to
The Isoray Cesium-131 Implant Devices combined with MRI Markers will be used to facilitate the anatomical location of seeds after they have been implanted in the prostate of a patient with confirmed prostatic malignancy. The PL-8 device is preloaded strands with Markers in 18G needles.
KXK
Source, Brachytherapy, Radionuclide
2
PL-8 Cs-131 Brachytherapy Seeds Preloaded Strands in 18G Needles with MRI Marker
The Isoray Cesium-131 Implant Devices combined with MRI Markers will be used to
The Isoray Cesium-131 Implant Devices combined with MRI Markers will be used to facilitate the anatomical location of seeds after they have been implanted in the prostate of a patient with confirmed prostatic malignancy. The PL-7 device is preloaded strands with Markers.
KXK
Source, Brachytherapy, Radionuclide
2
PL-7 Cs-131 Brachytherapy Seeds in Preloaded Strands with MRI Markers
2 - 1.10mm x 0.50cm VISICOIL separated by 20mm PGLA spacer (Stranded with PGLA S
2 - 1.10mm x 0.50cm VISICOIL separated by 20mm PGLA spacer (Stranded with PGLA Sleeve) loaded in an 17 gauge pre-waxed brachytherapy needle 20cm in length.
2 - 1.10mm x 0.50cm VISICOIL separated by a 15mm PGLA spacer (Stranded with PGLA
2 - 1.10mm x 0.50cm VISICOIL separated by a 15mm PGLA spacer (Stranded with PGLA Sleeve) loaded in an 17 gauge pre-waxed brachytherapy needle 20cm in length.
2 - 0.75mm x 0.50cm VISICOIL separated by 20mm PGLA spacer (Stranded with PGLA S
2 - 0.75mm x 0.50cm VISICOIL separated by 20mm PGLA spacer (Stranded with PGLA Sleeve) loaded in an 18 gauge pre-waxed brachytherapy needle 12cm in length.
2 - 0.75mm x 0.50cm VISICOIL separated by 20mm PGLA spacer (Stranded with PGLA S
2 - 0.75mm x 0.50cm VISICOIL separated by 20mm PGLA spacer (Stranded with PGLA Sleeve) loaded in an 18 gauge pre-waxed brachytherapy needle 20cm in length.
2 - 0.75mm x 0.50cm VISICOIL separated by 15mm PGLA spacer (Stranded with PGLA S
2 - 0.75mm x 0.50cm VISICOIL separated by 15mm PGLA spacer (Stranded with PGLA Sleeve) loaded in an 18 gauge pre-waxed brachytherapy needle 12cm in length.
2 - 0.75mm x 0.50cm VISICOIL separated by a 15mm PGLA Spacer (Stranded with PGLA
2 - 0.75mm x 0.50cm VISICOIL separated by a 15mm PGLA Spacer (Stranded with PGLA Sleeve) loaded in an 18 gauge pre-waxed brachytherapy needle 20cm in length.
2 - 1.10mm x 0.50cm VISICOIL separated by a 20mm PGLA spacer (Non-Stranded) load
2 - 1.10mm x 0.50cm VISICOIL separated by a 20mm PGLA spacer (Non-Stranded) loaded in an 17 gauge pre-waxed brachytherapy needle 20cm in length.
2 - 1.10mm x 0.50cm VISICOIL separated by a 15mm PGLA spacer (Non-Stranded) load
2 - 1.10mm x 0.50cm VISICOIL separated by a 15mm PGLA spacer (Non-Stranded) loaded in an 17 gauge pre-waxed brachytherapy needle 20cm in length.
2 - 0.75mm x 0.50cm VISICOIL separated by a 20mm PGLA spacer (Non-Stranded) load
2 - 0.75mm x 0.50cm VISICOIL separated by a 20mm PGLA spacer (Non-Stranded) loaded in an 18 gauge pre-waxed brachytherapy needle 12cm in length.
2 - 0.75mm x 0.50cm VISICOIL separated by a 20mm PGLA spacer (Non-Stranded) load
2 - 0.75mm x 0.50cm VISICOIL separated by a 20mm PGLA spacer (Non-Stranded) loaded in an 18 gauge pre-waxed brachytherapy needle 20cm in length.
2 - 0.75mm x 0.50cm VISICOIL separated by a 15mm PGLA spacer (Non-Stranded) load
2 - 0.75mm x 0.50cm VISICOIL separated by a 15mm PGLA spacer (Non-Stranded) loaded in an 18 gauge pre-waxed brachytherapy needle.
2 - 0.75mm x 0.50cm VISICOIL separated by a 15mm PGLA spacer (Non-Stranded) load
2 - 0.75mm x 0.50cm VISICOIL separated by a 15mm PGLA spacer (Non-Stranded) loaded in an 18 gauge pre-waxed brachytherapy needle 12cm in length.
2 - 0.50mm x 0.5cm VISICOIL separated by a 20mm PGLA spacer (Non-Stranded) loade
2 - 0.50mm x 0.5cm VISICOIL separated by a 20mm PGLA spacer (Non-Stranded) loaded in an 20 gauge pre-waxed brachytherapy needle.
2 - 0.50mm x 0.5cm VISICOIL separated by a 15mm spacer (Non-Stranded) loaded in
2 - 0.50mm x 0.5cm VISICOIL separated by a 15mm spacer (Non-Stranded) loaded in an 20 gauge pre-waxed brachytherapy needle.
2 - 0.50mm x 0.5cm VISICOIL MR separated by a 10mm spacer (Non-Stranded) loaded
2 - 0.50mm x 0.5cm VISICOIL MR separated by a 10mm spacer (Non-Stranded) loaded in an 21 gauge pre-waxed brachytherapy needle.
2 - 0.75mm x 0.50cm VISICOIL MR separated by 20mm PGLA spacer (Stranded with PGL
2 - 0.75mm x 0.50cm VISICOIL MR separated by 20mm PGLA spacer (Stranded with PGLA Sleeve) loaded in an 18 gauge pre-waxed brachytherapy needle 20cm in length.
2 - 0.75mm x 0.50cm VISICOIL MR separated by a 15mm PGLA Spacer (Stranded with P
2 - 0.75mm x 0.50cm VISICOIL MR separated by a 15mm PGLA Spacer (Stranded with PGLA Sleeve) loaded in an 18 gauge pre-waxed brachytherapy needle 20cm in length.
2 - 0.75mm x 0.50cm VISICOIL MR separated by a 20mm PGLA spacer (Non-Stranded) l
2 - 0.75mm x 0.50cm VISICOIL MR separated by a 20mm PGLA spacer (Non-Stranded) loaded in an 19 gauge pre-waxed brachytherapy needle.
2 - 0.75mm x 0.50cm VISICOIL MR Platinum separated by a 15mm PGLA spacer (Non-St
2 - 0.75mm x 0.50cm VISICOIL MR Platinum separated by a 15mm PGLA spacer (Non-Stranded) loaded in an 19 gauge pre-waxed brachytherapy needle.
2 - 0.50mm x 0.5cm VISICOIL MR separated by a 20mm spacer (Non-Stranded) loaded
2 - 0.50mm x 0.5cm VISICOIL MR separated by a 20mm spacer (Non-Stranded) loaded in an 21 gauge pre-waxed brachytherapy needle.
2 - 0.50mm x 0.5cm VISICOIL MR separated by a 15mm spacer (Non-Stranded) loaded
2 - 0.50mm x 0.5cm VISICOIL MR separated by a 15mm spacer (Non-Stranded) loaded in an 21 gauge pre-waxed brachytherapy needle.
2 - 0.50mm x 0.5cm VISICOIL MR separated by a 15mm spacer (Non-Stranded) loaded
2 - 0.50mm x 0.5cm VISICOIL MR separated by a 15mm spacer (Non-Stranded) loaded in an 20 gauge pre-waxed brachytherapy needle.
The SIRIUS MRI Marker NS is a component device indicated as an accessory for use
The SIRIUS MRI Marker NS is a component device indicated as an accessory for use in conjunction with brachytherapy seed carrier sleeves and radionuclide brachytherapy sources containing one of the following isotopes: Iodine 125 (125I), Palladium 103 (103Pd) or Cesium 131 (131Cs). It is indicated for permanent interstitial implantation in the prostate of patients with confirmed prostatic malignancy.
The SIRIUS MRI Marker is a component device indicated as an accessory for use in
The SIRIUS MRI Marker is a component device indicated as an accessory for use in conjunction with brachytherapy seed carriersleeves and radionuclide brachytherapy sources containing one of the following isotopes: Iodine 125 (125I), Palladium 103(103Pd) or Cesium 131 (131Cs). It is indicated for permanent interstitial implantation in the prostate of patients with confirmedprostatic malignancy.
The SIRIUS MRI Marker is a component device indicated as an accessory for use in
The SIRIUS MRI Marker is a component device indicated as an accessory for use in conjunction with brachytherapy seed carrier sleeves and radionuclide brachytherapy sources containing one of the following isotopes: Iodine 125 (125I), Palladium 103 (103Pd) or Cesium 131 (131Cs). It is indicated for permanent interstitial implantation in the prostate of patients with confirmed prostatic malignancy.